SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brian Pastor who wrote (490)11/7/1997 11:10:00 AM
From: bysfbay  Read Replies (2) of 998
 
The scenario of speculators shorting CEPH stock and buying calls to protect themselves fits with what I am observing. The majority interest is in the Nov 12-1/2c which protects them from the Nov 11 Myotrophin thumbs up/down/sideways date. The stock price is soft, not what you'd expect if speculation is for FDA approval.

[BTW: Reply #475 (my inside source... janitor at FDA) is passing along
insider information or spreading rumors to manipulate stock
price. This is unfair, uncool, and dare I say, unethical.]

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News